COVID - Pfizer

Service Description

Pfizer-BioNTech COVID-19 vaccine is a two-dose series (given 21 days apart) for the prevention of coronavirus caused by severe acute respiratory syndrome. FDA approved for individuals 16 years of age and older, with EUA for ages 12-15. Vaccine has a 95.3% efficacy in severe diseases.